Use of Lycorine as an immunosuppressor

US4699912A · kind A · utility

Assignee

• Behringwerke Aktiengesellschaft · DE

Inventors

• Gerhard Dickneite · Marburg, DE
• Hans-Ulrich Schorlemmer · Marburg, DE
• Hans-Harald Sedlacek · Marburg, DE

Key dates

• Filing date: Jul 12, 1985
• Grant date: Oct 13, 1987
• Expiry date: Jul 12, 2005

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P37/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The fact that Lycorine can be used for suppression of the immune system of mammals is described. Lycorine is therefore suitable for the therapy of autoimmune diseases, immune complex diseases and allergic and rheumatic conditions and for prophylaxis against transplant rejections.